BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33577898)

  • 1. Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients.
    Sayyid RK; Klotz L; Benton JZ; Lodh A; Lambert JH; Woodruff P; Lokeshwar SD; Madi R; Goldberg H; Terris MK; Wallis CJD; Klaassen Z
    Urology; 2021 Sep; 155():117-123. PubMed ID: 33577898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
    Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
    BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.
    Wong AT; Safdieh JJ; Rineer J; Weiner J; Schwartz D; Schreiber D
    Int Urol Nephrol; 2015 Oct; 47(10):1629-34. PubMed ID: 26329748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-Based Assessment of Determining Treatments for Prostate Cancer.
    Chamie K; Williams SB; Hu JC
    JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice.
    Sayyid RK; Klotz L; Benton JZ; Ma M; Woodruff P; Satkunasivam R; Terris MK; Wallis CJD; Klaassen Z
    Can Urol Assoc J; 2022 Jan; 16(1):E7-E14. PubMed ID: 34464250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sociodemographic factors on treatment's choice for localized prostate cancer in Portugal.
    Pereira-Lourenço M; Vieira E Brito D; Peralta JP; Godinho R; Conceiçao P; Reis M; Rabaça C; Sismeiro A
    Arch Ital Urol Androl; 2020 Apr; 92(1):45-49. PubMed ID: 32255317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of clinically localized prostate cancer patients managed with initial monitoring approach versus upfront local treatment: a North American population-based study.
    Abdel-Rahman O
    Clin Transl Oncol; 2019 Dec; 21(12):1673-1679. PubMed ID: 30929179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
    Gray PJ; Lin CC; Cooperberg MR; Jemal A; Efstathiou JA
    Eur Urol; 2017 May; 71(5):729-737. PubMed ID: 27597241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Surveillance for Men with Intermediate Risk Prostate Cancer.
    Agrawal V; Ma X; Hu JC; Barbieri CE; Nagar H
    J Urol; 2021 Jan; 205(1):115-121. PubMed ID: 32658588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.
    Butler SS; Mahal BA; Lamba N; Mossanen M; Martin NE; Mouw KW; Nguyen PL; Muralidhar V
    Cancer; 2019 Sep; 125(18):3164-3171. PubMed ID: 31150125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis.
    Gandaglia G; Sun M; Trinh QD; Becker A; Schiffmann J; Hu JC; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI; Abdollah F
    BJU Int; 2014 Dec; 114(6b):E62-E69. PubMed ID: 24467651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015.
    Butler SS; Loeb S; Cole AP; Zaslowe-Dude C; Muralidhar V; Kim DW; Schaeffer EM; Trinh QD; Nguyen PL; Mahal BA
    Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):179-183. PubMed ID: 31591454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study.
    Holmes JA; Wang AZ; Hoffman KE; Hendrix LH; Rosenman JG; Carpenter WR; Godley PA; Chen RC
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):88-94. PubMed ID: 22300560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic upgrading in favorable intermediate risk active surveillance patients: Clinical heterogeneity and implications for active surveillance decision.
    Sayyid RK; Reed WC; Benton JZ; Lodh A; Woodruff P; Lambert JH; Terris MK; Wallis CJD; Klaassen Z
    Urol Oncol; 2021 Nov; 39(11):782.e7-782.e14. PubMed ID: 33766466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.
    Huang D; Ruan X; Huang J; Zhang N; Jiang G; Gao Y; Xu D; Na R
    Cancer Med; 2023 Apr; 12(8):9868-9878. PubMed ID: 36727535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.
    Moschini M; Fossati N; Sood A; Lee JK; Sammon J; Sun M; Pucheril D; Dalela D; Montorsi F; Karnes RJ; Briganti A; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2018 Jan; 4(1):68-74. PubMed ID: 28753764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.
    Oake JD; Harasemiw O; Tangri N; Ferguson TW; Saranchuk JW; Bansal RK; Drachenberg DE; Nayak JG
    J Urol; 2021 Nov; 206(5):1204-1211. PubMed ID: 34181467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hospitalisation after primary treatment for prostate cancer.
    Williams SB; Duan Z; Chamie K; Hoffman KE; Smith BD; Hu JC; Shah JB; Davis JW; Giordano SH
    BJU Int; 2017 Jul; 120(1):48-55. PubMed ID: 27561186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marriage and ethnicity predict treatment in localized prostate carcinoma.
    Denberg TD; Beaty BL; Kim FJ; Steiner JF
    Cancer; 2005 May; 103(9):1819-25. PubMed ID: 15795905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.